Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Endocrine Research
Studies conducted at Washington State University on endocrine research recently published
May 20th, 2008
New research, 'Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease,' is the subject of a report. "The ability of an endocrine disruptor exposure during gonadal sex determination to promote a transgenerational prostate disease phenotype was investigated in the current study. Exposure of an F0 gestating female rat to the endocrine disruptor vinclozolin during F1 embryo gonadal sex determination promoted a transgenerational adult onset prostate disease phenotype," investigators in the United States report. "The prostate disease phenotype and physiological parameters were determined for males from F1 to F4...
Source: Cancer Weekly (2008-05-20)
|
